6-N-(5-tert-butyl-1H-pyrazol-3-yl)-4-N-[1-(2,4-difluorophenyl)ethyl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-[5-(furan-2-yl)-1H-pyrazol-3-yl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-2-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-4-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine
C78H72F8N26O — CID 158230214
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-N-(5-tert-butyl-1H-pyrazol-3-yl)-4-N-[1-(2,4-difluorophenyl)ethyl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-[5-(furan-2-yl)-1H-pyrazol-3-yl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-2-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-4-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine
6-N-(5-tert-butyl-1H-pyrazol-3-yl)-4-N-[1-(2,4-difluorophenyl)ethyl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-[5-(furan-2-yl)-1H-pyrazol-3-yl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-2-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-4-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine (PubChem CID 158230214) has the molecular formula C78H72F8N26O and a molecular weight of 1541.60 g/mol. Its IUPAC name is 6-N-(5-tert-butyl-1H-pyrazol-3-yl)-4-N-[1-(2,4-difluorophenyl)ethyl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-[5-(furan-2-yl)-1H-pyrazol-3-yl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-2-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-4-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine.
Molecular Properties
| Compound Name | 6-N-(5-tert-butyl-1H-pyrazol-3-yl)-4-N-[1-(2,4-difluorophenyl)ethyl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-[5-(furan-2-yl)-1H-pyrazol-3-yl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-2-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-4-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine |
|---|---|
| PubChem CID | 158230214 |
| Molecular Formula | C78H72F8N26O |
| Molecular Weight | 1541.60 g/mol |
| Exact Mass | 1540.63 |
| IUPAC Name | 6-N-(5-tert-butyl-1H-pyrazol-3-yl)-4-N-[1-(2,4-difluorophenyl)ethyl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-[5-(furan-2-yl)-1H-pyrazol-3-yl]pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-2-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine;4-N-[1-(2,4-difluorophenyl)ethyl]-6-N-(5-pyridin-4-yl-1H-pyrazol-3-yl)pyrimidine-4,6-diamine |
| SMILES | CC(Nc1cc(Nc2cc(-c3ccccn3)[nH]n2)ncn1)c1ccc(F)cc1F.CC(Nc1cc(Nc2cc(-c3ccco3)[nH]n2)ncn1)c1ccc(F)cc1F.CC(Nc1cc(Nc2cc(-c3ccncc3)[nH]n2)ncn1)c1ccc(F)cc1F.CC(Nc1cc(Nc2cc(C(C)(C)C)[nH]n2)ncn1)c1ccc(F)cc1F |
| InChI | InChI=1S/2C20H17F2N7.C19H16F2N6O.C19H22F2N6/c1-12(15-3-2-14(21)8-16(15)22)26-18-10-19(25-11-24-18)27-20-9-17(28-29-20)13-4-6-23-7-5-13;1-12(14-6-5-13(21)8-15(14)22)26-18-10-19(25-11-24-18)27-20-9-17(28-29-20)16-4-2-3-7-23-16;1-11(13-5-4-12(20)7-14(13)21)24-17-9-18(23-10-22-17)25-19-8-15(26-27-19)16-3-2-6-28-16;1-11(13-6-5-12(20)7-14(13)21)24-16-9-17(23-10-22-16)25-18-8-15(26-27-18)19(2,3)4/h2*2-12H,1H3,(H3,24,25,26,27,28,29);2-11H,1H3,(H3,22,23,24,25,26,27);5-11H,1-4H3,(H3,22,23,24,25,26,27) |
| InChIKey | GEHCWVQUQYGDFB-UHFFFAOYSA-N |
| XLogP | 18.26 |
| TPSA | 353.00 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 23 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 113 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1541.60 |
| LogP ≤ 5 | 18.26 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 23 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158230214 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.